PHIOPhio Pharmaceuticals Corp.

$13M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$4M

Operating Income

-$9M

Net Income

-$9M

EPS (Diluted)

$-207.25

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$136,000

Balance Sheet

Total Assets

$16M

Total Liabilities

$3M

Stockholders' Equity

$13M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$21,000	-100.0%
Gross Profit	-$4M	$21,000	-17795.2%
Operating Income	-$9M	-$9M	+2.2%
Net Income	-$9M	-$9M	+1.3%

PHIO FY 2020 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena